AUM$10.6M
Expense Ratio0.45%
NAV$20.10
Holdings89
InceptionDec 6, 2021
Price Chart
Key Statistics
Previous Close
—Day Range
N/A52-Week Range
N/AAvg Volume
—Dividend Yield
—Expense Ratio
0.45%AUM
$10.6MShares Outstanding
—Sector Breakdown
| Sector | Weight % |
|---|---|
| Healthcare | 92.41% |
| Basic Materials | 4.46% |
| Consumer Defensive | 3.13% |
Country Allocation
| Country | Weight % |
|---|---|
| United States | 79.67% |
| Denmark | 4.64% |
| United Kingdom | 4.54% |
| Switzerland | 3.90% |
| Germany | 3.80% |
| Netherlands | 1.92% |
| Japan | 1.08% |
| Australia | 0.27% |
| Other | 0.18% |
Fund Information
- Issuer
- WisdomTree
- Category
- Healthcare
- Inception Date
- Dec 6, 2021
- Description
- The WisdomTree BioRevolution UCITS ETF (the “Fund”) seeks to track the price and yield performance, before fees and expenses, of the WisdomTree BioRevolution ESG Screened Index (the "Index").
Similar ETFs
The WisdomTree BioRevolution UCITS ETF - USD Acc (WDNA.L) is an exchange-traded fund issued by WisdomTree that launched on Dec 6, 2021. It currently manages $10.6M in assets under management. The fund charges an expense ratio of 0.45%. The fund holds 89 securities in its portfolio. It falls under the Healthcare category.
Top 10 holdings represent 28.2% of the fund
| Rank | Symbol | Name | Weight % | Shares | Market Value |
|---|---|---|---|---|---|
| 1 | MRNA | Moderna Inc | 4.72% | 9,338 | $499K |
| 2 | JNJ | Johnson & Johnson | 3.08% | 1,345 | $326K |
| 3 | STOK | Stoke Therapeutics Inc | 3.06% | 8,843 | $323K |
| 4 | LLY | Eli Lilly & Co | 2.79% | 302 | $295K |
| 5 | PFE | Pfizer Inc | 2.59% | 10,197 | $274K |
| 6 | GPCR | Structure Therapeutics Inc | 2.56% | 4,948 | $270K |
| 7 | UTHR | United Therapeutics Corp | 2.48% | 491 | $262K |
| 8 | AMGN | Amgen Inc | 2.43% | 697 | $256K |
| 9 | NTRA | Natera Inc | 2.32% | 1,285 | $245K |
| 10 | AZN | ASTRAZENECA PLC USD 0.2500 | 2.20% | 1,208 | $233K |
| 11 | TWST | Twist Bioscience Corp | 2.16% | 5,304 | $228K |
| 12 | BNTX | Biontech Se-ADR | 2.10% | 2,467 | $222K |
| 13 | FOLD | Amicus Therapeutics Inc | 2.10% | 15,409 | $221K |
| 14 | BEAM | Beam Therapeutics Inc | 2.05% | 8,470 | $217K |
| 15 | IONS | Ionis Pharmaceuticals Inc | 1.93% | 2,815 | $204K |
Page 1 of 2
Detailed Returns
| Period | Return | ETF | Cat. Avg | vs Avg |
|---|---|---|---|---|
| 1D | — | — |
Moving Averages
20-Day MA
—
50-Day MA
—
200-Day MA
—
Price with Moving Averages
Support & Resistance
52-Week High
—
Current Price
—
52-Week Low
—
Current Yield
—
Annual Dividend
—
Frequency
—
Last Ex-Date
—
Dividends
No dividend data available for this ETF.
Category Comparison
| Metric | WDNA.L | Healthcare(223 ETFs) |
|---|---|---|
| Fund Info | ||
| Expense Ratio | 0.45% | 0.60% |
| AUM | $10.6M | $1.24B |
| Dividend Yield | — | 2.75% |
| Avg Volume | — | 800.9K |
| Holdings | 89 | 171 |
| Performance | ||
| 1-Month Return | — | -4.57% |
| 6-Month Return | — | +4.90% |
| YTD Return | — | -1.70% |
| 1-Year Return | — | +15.18% |
Compare with Another ETF
Search for an ETF to compare with WDNA.L: